REQUEST A DEMO
Total
USD $0.00
Search more companies

Vexxa Lifesciences Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Vexxa Lifesciences Private Limited Profile Updated: December 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Vexxa Lifesciences Private Limited is an unlisted company, incorporated on 03/11/2011. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U24230MH2011PTC284061 and registration number is 284061. The company is a trade company, it is engaged in wholesale trading.

Headquarters
401 4Th Floor Mehta Mahal 15Th Mathew Road Opera House Charni Road (East) Mumbai In-Mh In 400004
Mumbai; Maharashtra; Postal Code: 400004

Contact Details: Purchase the Vexxa Lifesciences Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Vexxa Lifesciences Private Limited report to view the information.
Registered Capital:
Purchase the Vexxa Lifesciences Private Limited report to view the information.
Incorporation Date:
November 03, 2011
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Vexxa Lifesciences Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
16.74%
Total operating revenue
17.36%
Operating profit (EBIT)
-41.35%
EBITDA
-35.78%
Net Profit (Loss) for the Period
-42.72%
Total assets
-1.7%
Total equity
7.36%
Operating Profit Margin (ROS)
-1.39%
Net Profit Margin
-1.01%
Return on Equity (ROE)
-5.99%
Quick Ratio
-0.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?